[1. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med. 2003; 349:776-88.10.1056/NEJMra021561]Search in Google Scholar
[2. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine clinical practice guideline. J Clin Endocrinol Metab. 2010; 95:4133-60.10.1210/jc.2009-2631]Search in Google Scholar
[3. Soliman AT, AlLamki M, AlSalmi I, Asfour M. Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog. Metabolism. 1997; 46:513-7.10.1016/S0026-0495(97)90186-4]Search in Google Scholar
[4. Muirhead S, Sellers EA, Guyda H. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia. J Pediatr. 2002; 141: 247-52.10.1067/mpd.2002.12660112183722]Search in Google Scholar
[5. Eugster EA, Dimeglio LA, Wright JC, Freidenberg GR, Seshadri R, Pescovitz OH. Height outcome in congenital adrenal hyperplasia caused by 21- hydroxylase deficiency: a meta-analysis. J Pediatr. 2001; 138:26-3210.1067/mpd.2001.11052711148508]Search in Google Scholar
[6. Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty. J Clin Endocrinol Metab. 2007; 92:1635-910.1210/jc.2006-210917299071]Search in Google Scholar
[7. Trinh L, Nimkarn S, New MI, Lin-Su K. Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Pediatr Endocrinol Metab. 2007; 20:883-91]Search in Google Scholar
[8. Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropulos JF, Elamin KB, et al. Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2010; 95:4161-72.10.1210/jc.2009-261620823467]Search in Google Scholar
[9. Somboonnithiphol K, Panamonta O, Kiatchoosakun P, Jirapradittha J, Panamonta M, Lumbiganon P, et al. Newborn screening for congenital adrenal hyperplasia in Srinagarind Hospital, Khon Kaen University, Thailand. Asian Biomed. 2011; 5:855-9.]Search in Google Scholar
[10. Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Sahakitrungrueng T. Pubertal growth in normal Thai children: a longitudinal study. Asian Biomed. 2010; 4:793-5.10.2478/abm-2010-0103]Search in Google Scholar
[11. Manoli I, Kanaka-Gantenbein CH, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome. Clinical Endocrinology. 2002; 57:669-76.10.1046/j.1365-2265.2002.01645.x12390343]Search in Google Scholar
[12. Janejai N, Krasao P, Phansang J, Pankarnjanato R, Charoensiriwatana W. Congenital adrenal hyperplasia: should nationwide screening be implemented in Thailand? Southeast Asian J Trop Med Public Health. 2003; 34 Suppl 3:170-3.]Search in Google Scholar
[13. Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation. J Clin Endocrinol Metab. 2009; 94:3882-8.10.1210/jc.2009-094219622620]Search in Google Scholar
[14. Mikhail G. Hormone secretion by the human ovaries. Gynecol Invest. 1970; 1:5-20.10.1159/000301902]Search in Google Scholar
[15. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011; 32:81-151.10.1210/er.2010-0013]Search in Google Scholar
[16. Scholler R, Nahoul K, Castanier M, Rotman J, Salat- Baroux J. Testicular secretion of conjugated and unconjugated steroids in normal adults and in patients with varicocele. Baseline levels and timecourse response to hCG administration. J Steroid Biochem. 1984; 20:203-15.10.1016/0022-4731(84)90207-3]Open DOISearch in Google Scholar
[17. Völkl TM, Simm D, Beier C, Dörr HG. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics. 2006; 117:e98-105.10.1542/peds.2005-100516396852]Search in Google Scholar
[18. Finkielstain GP, Kim MS, Sinaii N, Nishitani M, Van Ryzin C, Hill SC, et al. Clinical Characteristics of a Cohort of 244 Patients with Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2012; 97: 4429-38.10.1210/jc.2012-2102351354222990093]Search in Google Scholar
[19. Lin-Su K, Vogiatzi MG, Marshall I, Harbison MD, Macapagal MC, Betensky B, et al. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2005; 90:3318-25.10.1210/jc.2004-212815797962]Search in Google Scholar
[20. Longui CA, Kochi C, Calliari LE, Modkovski MB, Soares M, Alves EF, et al. Near-final height in patients with congenital adrenal hyperplasia treated with combined therapy using GH and GnRHa. Arq Bras Endocrinol Metabol. 2011; 55:661-4.10.1590/S0004-2730201100080002322218451]Search in Google Scholar